Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP1LC3B | Q9GZQ8 | 2/20 | 0.40 |
| ▸ | FURIN | P09958 | 3/20 | 0.38 |
| ▸ | SIRT2 | Q8IXJ6 | 7/20 | 0.37 |
| ▸ | SIRT1 | Q96EB6 | 6/20 | 0.37 |
| ▸ | FAP | Q12884 | 3/20 | 0.36 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.36 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26008568 | 0.94 | MAP1LC3B (0.40) | MAP1LC3BFURINSIRT2SIRT1FAP | |
| SCHEMBL16330578 | 0.92 | MAP1LC3B (0.41) | MAP1LC3BFURINSIRT2SIRT1FAP | |
| SCHEMBL16925417 | 0.91 | MAP1LC3B (0.42) | MAP1LC3BFURINSIRT2SIRT1FAP | |
| SCHEMBL19982142 | 0.91 | MAP1LC3B (0.41) | MAP1LC3BSIRT2SIRT1FAPSIRT5 | |
| SCHEMBL20375599 | 0.90 | FAP (0.42) | MAP1LC3BFURINSIRT2SIRT1FAP | |
| SCHEMBL30697716 | 0.90 | FURIN (0.40) | MAP1LC3BFURINFAPHTT | |
| SCHEMBL18893500 | 0.89 | MAP1LC3B (0.40) | MAP1LC3BFURINSIRT2SIRT1FAP | |
| SCHEMBL18893501 | 0.89 | MAP1LC3B (0.40) | MAP1LC3BFURINSIRT2SIRT1FAP | |
| SCHEMBL10270090 | 0.89 | FURIN (0.39) | MAP1LC3BFURINFAP | |
| SCHEMBL9943154 | 0.89 | FURIN (0.46) | MAP1LC3BFURINFAPHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230340020-A1 | PEPTIDE LIGANDS FOR BINDING TO MT1-MMP | BICYCLETX LIMITED (GB) | 2023-10-26 | — | — | US | disclosed |
| US-11730819-B2 | Peptide derivatives having novel linkage structures | BICYCLETX LIMITED (GB) | 2023-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230340020-A1 | PEPTIDE LIGANDS FOR BINDING TO MT1-MMP | MMP11, MMP3, ANPEP | MAP1LC3B 2687/4885FURIN 668/4885SIRT2 4168/4885 |
| US-11730819-B2 | Peptide derivatives having novel linkage structures | DNPEP, LNPEP, ANPEP | MAP1LC3B 1462/4885FURIN 227/4885SIRT2 2366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.